These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Quantitative Proteomic Analysis of Mosquito C6/36 Cells Reveals Host Proteins Involved in Zika Virus Infection. Xin QL; Deng CL; Chen X; Wang J; Wang SB; Wang W; Deng F; Zhang B; Xiao G; Zhang LK J Virol; 2017 Jun; 91(12):. PubMed ID: 28404849 [TBL] [Abstract][Full Text] [Related]
10. New drug targets for hepatitis C and other Flaviviridae viruses. Paula T; Pablo R; Eugenia V; Pablo B; Sabino P; José M; Antonio M; Dolores HM; Pablo L; Javier GS; Vincente S Infect Disord Drug Targets; 2009 Apr; 9(2):133-47. PubMed ID: 19275702 [TBL] [Abstract][Full Text] [Related]
11. Flaviviridae virus nonstructural proteins 5 and 5A mediate viral immune evasion and are promising targets in drug development. Chen S; Yang C; Zhang W; Mahalingam S; Wang M; Cheng A Pharmacol Ther; 2018 Oct; 190():1-14. PubMed ID: 29742479 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors compounds of the flavivirus replication process. García LL; Padilla L; Castaño JC Virol J; 2017 May; 14(1):95. PubMed ID: 28506240 [TBL] [Abstract][Full Text] [Related]
13. Perspectives for the treatment of infections with Flaviviridae. Leyssen P; De Clercq E; Neyts J Clin Microbiol Rev; 2000 Jan; 13(1):67-82, table of contents. PubMed ID: 10627492 [TBL] [Abstract][Full Text] [Related]
14. Rewiring cellular networks by members of the Flaviviridae family. Neufeldt CJ; Cortese M; Acosta EG; Bartenschlager R Nat Rev Microbiol; 2018 Feb; 16(3):125-142. PubMed ID: 29430005 [TBL] [Abstract][Full Text] [Related]
15. Xanthohumol enhances antiviral effect of interferon alpha-2b against bovine viral diarrhea virus, a surrogate of hepatitis C virus. Zhang N; Liu Z; Han Q; Chen J; Lv Y Phytomedicine; 2010 Apr; 17(5):310-6. PubMed ID: 19748253 [TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro. Vicenti I; Boccuto A; Giannini A; Dragoni F; Saladini F; Zazzi M Virus Res; 2018 Jan; 244():64-70. PubMed ID: 29113824 [TBL] [Abstract][Full Text] [Related]
17. Current approaches in antiviral drug discovery against the Flaviviridae family. Baharuddin A; Hassan AA; Sheng GC; Nasir SB; Othman S; Yusof R; Othman R; Rahman NA Curr Pharm Des; 2014; 20(21):3428-44. PubMed ID: 24001228 [TBL] [Abstract][Full Text] [Related]
18. In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus. Carvalho OV; Saraiva GL; Ferreira CG; Felix DM; Fietto JL; Bressan GC; Almeida MR; Silva Júnior A Can J Vet Res; 2014 Oct; 78(4):283-9. PubMed ID: 25355997 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay. Adcock RS; Chu YK; Golden JE; Chung DH Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709 [TBL] [Abstract][Full Text] [Related]